Analysis: Industry observers differ over future of big pharma stocks

10/12/2004 | NYTimes.com

Drug stocks have underperformed the broad market since February, and while financial analysts agree large pharmaceutical company stock prices are low, a looming election, patent expirations and hard bargaining by HMOs, among other factors, have many analysts disagreeing over what the future holds. Some analysts fear more regulatory pressure on drug companies with a change in presidents, while others see a Democratic president being held in check by a GOP Congress. Some are investing in other areas of health care, such as medical instruments and biotechnology.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA